Cartesian Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

RNAC
Cartesian Therapeutics

Last Price:

16.58

Seasonality Move:

13.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Cartesian Therapeutics Price Quote

$16.58

-0.36 (-2.13%)

(Updated: November 21, 2024 at 5:55 PM ET)

Cartesian Therapeutics Key Stats

Sell

Cartesian Therapeutics (RNAC) is a Sell

Day range:

$16.85 - $18.20

52-week range:

$11.67 - $42.60

Dividend yield:

P/E ratio:

0.00

P/S ratio:

3.45

P/B ratio:

627.6%

Volume:

114.4K

Avg. volume:

106.1K

1-year change:

-49.58%

Market cap:

$472M

Revenue:

$26M

EPS:

$-54.95

How Much Does Cartesian Therapeutics Make?

How Much Are Cartesian Therapeutics's Sales Annually?
RNAC Revenues are $26M
How Much Profit Does Cartesian Therapeutics's Make A Year?
RNAC net income is -$219.7M

Is Cartesian Therapeutics Growing As A Company?

What Is Cartesian Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.94%
What Is Cartesian Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Cartesian Therapeutics Stock Price Performance

Did Cartesian Therapeutics Stock Go Up Last Month?
Cartesian Therapeutics share price went down by -25.93% last month
Did RNAC's Share Price Rise Over The Last Year?
RNAC share price fell by -49.58% over the past 1 year

What Is Cartesian Therapeutics 52-Week High & Low?

What Is Cartesian Therapeutics’s 52-Week High Share Price?
Cartesian Therapeutics has traded as high as $42.60 over the past 52 weeks
What Is Cartesian Therapeutics’s 52-Week Low Share Price?
Cartesian Therapeutics has traded as low as $11.67 over the past 52 weeks

Cartesian Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cartesian Therapeutics?

How Much Debt Does Cartesian Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Cartesian Therapeutics Have?
Cash and short term investments quarterly total is $219.2M
What Is Cartesian Therapeutics’s Book Value Per Share?
Book value per share is 0.03

Is Cartesian Therapeutics Cash Flow Positive?

What Is RNAC Cash Flow From Operations?
Cash flow from operations (TTM) is -$40M
What Is Cartesian Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $181.7M
What Is Cartesian Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.9M

Cartesian Therapeutics Return On Invested Capital